Back to Search
Start Over
Small benefits in trastuzumab-related cardiotoxicity.
- Source :
-
The Lancet. Oncology [Lancet Oncol] 2017 Jan; Vol. 18 (1), pp. e5. Date of Electronic Publication: 2016 Dec 10. - Publication Year :
- 2017
- Subjects :
- Adrenergic beta-1 Receptor Antagonists adverse effects
Angiotensin-Converting Enzyme Inhibitors adverse effects
Bisoprolol adverse effects
Breast Neoplasms pathology
Cardiotoxicity
Female
Humans
Perindopril adverse effects
Randomized Controlled Trials as Topic
Stroke Volume drug effects
Time Factors
Treatment Outcome
Ventricular Dysfunction, Left chemically induced
Ventricular Dysfunction, Left diagnosis
Ventricular Dysfunction, Left physiopathology
Ventricular Function, Left drug effects
Ventricular Remodeling drug effects
Adrenergic beta-1 Receptor Antagonists therapeutic use
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Antineoplastic Agents, Immunological adverse effects
Bisoprolol therapeutic use
Breast Neoplasms drug therapy
Perindopril therapeutic use
Trastuzumab adverse effects
Ventricular Dysfunction, Left prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1474-5488
- Volume :
- 18
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Lancet. Oncology
- Publication Type :
- Periodical
- Accession number :
- 27956153
- Full Text :
- https://doi.org/10.1016/S1470-2045(16)30639-8